Integrated Biopharma Probability of Future OTC Stock Price Finishing Under 0.0108
| INBPDelisted Stock | USD 0.23 0.01 4.55% |
Integrated |
Integrated Biopharma Target Price Odds to finish below 0.0108
The tendency of Integrated OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.01 or more in 90 days |
| 0.23 | 90 days | 0.01 | near 1 |
Based on a normal probability distribution, the odds of Integrated Biopharma to drop to $ 0.01 or more in 90 days from now is near 1 (This Integrated Biopharma probability density function shows the probability of Integrated OTC Stock to fall within a particular range of prices over 90 days) . Probability of Integrated Biopharma price to stay between $ 0.01 and its current price of $0.23 at the end of the 90-day period is about 13.56 .
Given the investment horizon of 90 days Integrated Biopharma has a beta of 0.39. This usually indicates as returns on the market go up, Integrated Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Integrated Biopharma will be expected to be much smaller as well. Additionally Integrated Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Integrated Biopharma Price Density |
| Price |
Predictive Modules for Integrated Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Integrated Biopharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integrated Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Integrated Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Integrated Biopharma is not an exception. The market had few large corrections towards the Integrated Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Integrated Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Integrated Biopharma within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.13 | |
β | Beta against NYSE Composite | 0.39 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.03 |
Integrated Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Integrated Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Integrated Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Integrated Biopharma is not yet fully synchronised with the market data | |
| Integrated Biopharma had very high historical volatility over the last 90 days | |
| Integrated Biopharma has some characteristics of a very speculative penny stock | |
| Integrated Biopharma has a very high chance of going through financial distress in the upcoming years | |
| About 69.0% of the company shares are held by company insiders | |
| Latest headline from express.co.uk: Worlds longest football scarf created - measuring 100 metres long |
Integrated Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Integrated OTC Stock often depends not only on the future outlook of the current and potential Integrated Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Integrated Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.9 M |
Integrated Biopharma Technical Analysis
Integrated Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Integrated OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Integrated Biopharma. In general, you should focus on analyzing Integrated OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Integrated Biopharma Predictive Forecast Models
Integrated Biopharma's time-series forecasting models is one of many Integrated Biopharma's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Integrated Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Integrated Biopharma
Checking the ongoing alerts about Integrated Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Integrated Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Integrated Biopharma is not yet fully synchronised with the market data | |
| Integrated Biopharma had very high historical volatility over the last 90 days | |
| Integrated Biopharma has some characteristics of a very speculative penny stock | |
| Integrated Biopharma has a very high chance of going through financial distress in the upcoming years | |
| About 69.0% of the company shares are held by company insiders | |
| Latest headline from express.co.uk: Worlds longest football scarf created - measuring 100 metres long |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |